ChemoSen Cancer Research Results
ChemoSen, chemo-sensitization: Click to Expand ⟱
| Source: |
| Type: |
The effectiveness of chemotherapy by increasing cancer cell sensitivity to the drugs used to treat them, which is known as “chemo-sensitization”.
Chemo-Sensitizers:
-Curcumin
-Resveratrol
-EGCG
-Quercetin
-Genistein
-Berberine
-Piperine: alkaloid from black pepper
-Ginsenosides: active components of ginseng
-Silymarin
-Allicin
-Lycopene
-Ellagic acid
-caffeic acid phenethyl ester
-flavopiridol
-oleandrin
-ursolic acid
-butein
-betulinic acid
|
Scientific Papers found: Click to Expand⟱
| - |
in-vitro, |
HCC, |
Hep3B |
|
|
|
- |
in-vitro, |
HCC, |
HUH7 |
|
|
|
ChemoSen↓, Glycolysis↓, HK1↓, HK2↓, ATP↓,
ChemoSen↓, TumCG↓, TumCCA↑, ER Stress↑, Apoptosis↑, Casp↑, DR5↑,
ChemoSen↓, other↝, other↝,
eff↓, ChemoSen↓, RadioS↓, other↝,
| - |
in-vitro, |
BC, |
MCF-7 |
|
|
|
- |
in-vitro, |
BC, |
MDA-MB-231 |
|
|
|
eff↓, ROS↑, TumCP↑, NRF2↑, ChemoSen↓,
| - |
in-vitro, |
CRC, |
SW480 |
|
|
|
- |
in-vitro, |
CRC, |
HCT116 |
|
|
|
ChemoSen↓, Apoptosis↑,
ChemoSen↓, *antiOx↑, *lipid-P?,
AntiCan↑, TumCP↓, TumCG↓, selectivity↑, ChemoSen↓, RadioS↑, Insulin↓, *GlucoseCon↑, *ROS↓, *antiOx↑, *GSH↑, GSH↑, eff↑, polyA↓, TS↓, Raf↓, Akt↓, Casp9↑, Bak↑, P21↑, p27↑, Insulin↓, IGF-1↓,
*antiOx↑, *IronCh↑, *toxicity↓, *BioAv↓, *BioAv↑, DNAdam↑, TumCP↓, DR5↑, P53↑, JNK↑, BAX↑, cl‑Casp3↑, cl‑Casp8↑, cl‑Casp9↑, cl‑PARP↑, survivin↓, cycD1/CCND1↓, CycB/CCNB1↓, CDC2↓, P21↑, angioG↓, MMP2↓, AEG1↓, VEGF↓, VEGFR2↓, MMP9↓, CXCR4↓, PI3K↓, Akt↓, ERK↓, TumAuto↑, LC3B-II↑, EMT↓, E-cadherin↑, N-cadherin↓, Wnt↓, ROS↑, NICD↓, p‑GSK‐3β↓, iNOS↓, COX2↓, NRF2↑, Ca+2↑, ChemoSen↑, ChemoSen↓, IFN-γ↓, RadioS↑, MDM2↓, NOTCH1↓, AR↓, TIMP1↑, TIMP2↑, ER Stress↑, CDK2↓, Telomerase↓, p‑NF-kB↑, p‑cMyc↑, hTERT/TERT↓, RAS↓, YAP/TEAD↓, TAZ↓, NF-kB↓, NRF2↓, HO-1↓, MDR1↓,
antiOx↑, ChemoSen↓, RadioS↓,
AntiCan↑, e-pH↑, TumMeta↓, TumCI↓, TumCG↓, CD8+↑, NK cell↑, Remission↑, eff↑, ChemoSen↑, ChemoSen↓,
ChemoSen↓, RadioS↑, Inflam↓, AntiCan↑, Dose∅, mtDam↑, Apoptosis?, OCR↓, ATP↓, ROS↑, ROS↑, LDH↓, TP53↓, Casp3↓, BAX↓, P21↓, ROS↑, eNOS↑, iNOS↑, eff↑, hTERT/TERT↓, cycD1/CCND1↓, eff↑, eff↑, eff↑, eff↑, STAT3↓, TIMP1↓, IL4↓, IL10↓, OS↑, Dose∅, ER Stress↑, ROS↑, NF-kB↓, p65↓, MMP↓, TumAuto↑, LC3II↑, p62↓, TLR4↓, mtDam↑, LDH↓, ROS↑, Glycolysis↓, HK2↓, PFK↓, PKM2↓, LDH↓, IL10↓, HDAC8↓, eff↑, eff↑, P21↑,
ChemoSen↓, *ROS↓, *GSH↑, RenoP↑, hepatoP↑, COX2↓, NF-kB↓, chemoPv↑, neuroP↑, TumCCA↑, P21↑, p27↑, ROS↑, DNAdam↑, MUC4↓,
TumCP↓, TumCMig↓, MMP9↓, TumAuto↑, Apoptosis↑, TumCCA↓, TumMeta↓, ChemoSen↓,
TumCCA↑, Apoptosis↑, TumAuto↑, TumCI↓, TumCG↓, ChemoSen↓, ChemoSideEff↓, toxicity∅, eff↑, cycD1/CCND1↓, CDK4↓, eff↑, IKKα↓, NF-kB↓, other↑, p27↑, cMyc↓, i-ROS↑, Bcl-2↓, BAX↑, p38↑, MMP↓, Casp9↑, p‑ERK↓, RAS↓, MAPK↓, p‑P53↑, Casp8↑, Casp3↑, cJun↑, MMPs↓, eff↑, eff↑,
Showing Research Papers: 1 to 15 of 15
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 15
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress ⓘ
antiOx↑, 1, GSH↑, 1, HK1↓, 1, HO-1↓, 1, NRF2↓, 1, NRF2↑, 2, ROS↑, 8, i-ROS↑, 1,
Mitochondria & Bioenergetics ⓘ
ATP↓, 2, CDC2↓, 1, Insulin↓, 2, MMP↓, 2, mtDam↑, 2, OCR↓, 1, Raf↓, 1,
Core Metabolism/Glycolysis ⓘ
cMyc↓, 1, p‑cMyc↑, 1, Glycolysis↓, 2, HK2↓, 2, LDH↓, 3, PFK↓, 1, PKM2↓, 1, polyA↓, 1, TS↓, 1,
Cell Death ⓘ
Akt↓, 2, Apoptosis?, 1, Apoptosis↑, 4, Bak↑, 1, BAX↓, 1, BAX↑, 2, Bcl-2↓, 1, Casp↑, 1, Casp3↓, 1, Casp3↑, 1, cl‑Casp3↑, 1, Casp8↑, 1, cl‑Casp8↑, 1, Casp9↑, 2, cl‑Casp9↑, 1, DR5↑, 2, hTERT/TERT↓, 2, iNOS↓, 1, iNOS↑, 1, JNK↑, 1, MAPK↓, 1, MDM2↓, 1, NICD↓, 1, p27↑, 3, p38↑, 1, survivin↓, 1, Telomerase↓, 1, YAP/TEAD↓, 1,
Transcription & Epigenetics ⓘ
cJun↑, 1, other↑, 1, other↝, 3,
Protein Folding & ER Stress ⓘ
ER Stress↑, 3,
Autophagy & Lysosomes ⓘ
LC3B-II↑, 1, LC3II↑, 1, p62↓, 1, TumAuto↑, 4,
DNA Damage & Repair ⓘ
DNAdam↑, 2, P53↑, 1, p‑P53↑, 1, cl‑PARP↑, 1, TP53↓, 1,
Cell Cycle & Senescence ⓘ
CDK2↓, 1, CDK4↓, 1, CycB/CCNB1↓, 1, cycD1/CCND1↓, 3, P21↓, 1, P21↑, 4, TumCCA↓, 1, TumCCA↑, 3,
Proliferation, Differentiation & Cell State ⓘ
EMT↓, 1, ERK↓, 1, p‑ERK↓, 1, p‑GSK‐3β↓, 1, HDAC8↓, 1, IGF-1↓, 1, NOTCH1↓, 1, PI3K↓, 1, RAS↓, 2, STAT3↓, 1, TAZ↓, 1, TumCG↓, 4, Wnt↓, 1,
Migration ⓘ
AEG1↓, 1, Ca+2↑, 1, E-cadherin↑, 1, MMP2↓, 1, MMP9↓, 2, MMPs↓, 1, MUC4↓, 1, N-cadherin↓, 1, TIMP1↓, 1, TIMP1↑, 1, TIMP2↑, 1, TumCI↓, 2, TumCMig↓, 1, TumCP↓, 3, TumCP↑, 1, TumMeta↓, 2,
Angiogenesis & Vasculature ⓘ
angioG↓, 1, eNOS↑, 1, VEGF↓, 1, VEGFR2↓, 1,
Immune & Inflammatory Signaling ⓘ
COX2↓, 2, CXCR4↓, 1, IFN-γ↓, 1, IKKα↓, 1, IL10↓, 2, IL4↓, 1, Inflam↓, 1, NF-kB↓, 4, p‑NF-kB↑, 1, NK cell↑, 1, p65↓, 1, TLR4↓, 1,
Cellular Microenvironment ⓘ
e-pH↑, 1,
Hormonal & Nuclear Receptors ⓘ
AR↓, 1,
Drug Metabolism & Resistance ⓘ
ChemoSen↓, 15, ChemoSen↑, 2, Dose∅, 2, eff↓, 2, eff↑, 13, MDR1↓, 1, RadioS↓, 2, RadioS↑, 3, selectivity↑, 1,
Clinical Biomarkers ⓘ
AR↓, 1, hTERT/TERT↓, 2, LDH↓, 3, TP53↓, 1,
Functional Outcomes ⓘ
AntiCan↑, 3, chemoPv↑, 1, ChemoSideEff↓, 1, hepatoP↑, 1, neuroP↑, 1, OS↑, 1, Remission↑, 1, RenoP↑, 1, toxicity∅, 1,
Infection & Microbiome ⓘ
CD8+↑, 1,
Total Targets: 143
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress ⓘ
antiOx↑, 3, GSH↑, 2, lipid-P?, 1, ROS↓, 2,
Metal & Cofactor Biology ⓘ
IronCh↑, 1,
Core Metabolism/Glycolysis ⓘ
GlucoseCon↑, 1,
Drug Metabolism & Resistance ⓘ
BioAv↓, 1, BioAv↑, 1,
Functional Outcomes ⓘ
toxicity↓, 1,
Total Targets: 9
Scientific Paper Hit Count for: ChemoSen, chemo-sensitization
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:1106 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid
Home Page